Advertisement
Screener

SCHOLAR ROCK HOLDING CORPORATION (SRRK) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SCHOLAR ROCK HOLDING CORPORATION Cash Flow Breakdown

Cash flow breakdown shows where SCHOLAR ROCK HOLDING CORPORATION's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $300.04M went out.
  • Fiscal year ended 2025-12-31: from investing, $218.69M came in.
  • Fiscal year ended 2025-12-31: from financing, $228.40M came in.
  • Fiscal year ended 2025-12-31: change in cash, $147.05M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldOtherNot split outChange in cash
2025-12-31-$300.04M$218.69M-$25.52M$24.67M$91.66M$137.59M*$147.05M
2024-12-31-$200.95M-$76.06M$324.41M$28.61M*$76.02M
2023-12-31-$145.23M$41.14M$97.71M$3.00K$4.86M*-$1.51M
2022-12-31-$132.69M-$171.70M$195.31M-$109.56M
2021-12-31-$126.79M$134.31M$24.98M$13.10M-$20.00K$6.89M*$52.48M
2020-12-31-$60.27M-$63.50M$24.62M$215.92M-$19.00K$7.29M*$124.05M
2019-12-31-$63.12M-$62.24M-$365.00K$48.30M-$13.00K$961.00K*-$76.47M
2018-12-31$24.57M-$60.23M-$667.00K$94.94M-$6.00K$58.61M
2017-12-31-$21.74M$17.66M-$8.00K$50.51M*$46.43M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldOtherNot split outChange in cash
2026-06-30-$70.31M*-$5.50M*$0.00*$1.05M*$62.77M*$19.30M*
2026-03-31-$82.10M-$5.33M-$103.06M$196.68M$98.00M$2.16M*$106.35M
2025-12-31-$75.50M*$38.97M*$0.00*$0.00*$2.00K*$73.28M*
2025-09-30-$68.92M*$59.70M*$0.00*$0.00*$91.66M*$0.00*$52.81M*
2025-06-30-$76.94M*$85.47M*$0.00*$1.00K*$3.11M*$0.00*$3.37M*
2025-03-31-$78.67M$34.55M-$25.52M$24.67M$5.02M$2.00K-$39.95M
2024-12-31-$49.51M*-$195.37M*$18.44M*$327.93M*
2024-09-30-$52.45M*$35.31M*$211.00K*
2024-06-30-$49.20M*$50.62M*$47.00K*
2024-03-31-$49.78M$33.38M$419.00K$6.11M*-$9.88M
2023-12-31-$37.35M*-$25.13M*$92.49M*$0.00*$4.04M*
2023-09-30-$32.27M*-$8.47M*$0.00*$0.00*
2023-06-30-$32.55M*-$15.24M*$4.40M*$1.00K*
2023-03-31-$43.05M$89.98M$827.00K$2.00K$48.01M
2022-12-31-$28.91M*$77.00K*$0.00*-$970.00K*
2022-09-30-$26.48M*-$145.72M*-$455.00K*
2022-06-30-$34.74M*$44.52M*$2.00K*$195.77M*
2022-03-31-$42.56M-$70.58M$481.00K-$112.66M
2021-12-31-$32.45M*$29.46M*$1.62M*-$1.00K*$38.08M*
2021-09-30-$35.98M*$3.28M*$1.92M*-$9.00K*
2021-06-30-$31.81M*$79.02M*$611.00K*-$4.00K*
2021-03-31-$26.54M$22.56M$2.74M-$6.00K-$1.25M
2020-12-31-$19.68M*-$122.64M*$5.92M*-$4.00K*$240.54M*
2020-09-30-$23.39M*-$35.87M*$374.00K*-$6.00K*
2020-06-30-$19.83M*$38.93M*$598.00K*-$3.00K*
2020-03-31$2.64M$56.09M$405.00K-$6.00K$59.13M
2019-12-31-$16.07M*$21.21M*$0.00*-$48.00K*-$3.00K*$869.00K*
2019-09-30-$15.11M*-$72.17M*$0.00*$6.13M*-$4.00K*
2019-06-30-$16.41M*$21.10M*-$198.00K*$79.00K*-$3.00K*$42.22M*
2019-03-31-$15.53M-$32.38M-$167.00K$13.00K-$3.00K-$48.06M
2018-12-31$55.09M*-$60.94M*-$167.00K*$17.10M*-$4.00K*
2018-09-30-$9.01M*-$598.00K*-$167.00K*-$1.30M*
2018-06-30-$11.63M*$24.89M*-$166.00K*$77.80M$1.34M*
2018-03-31-$9.88M-$23.59M-$167.00K-$33.64M
2017-12-31-$6.06M*$5.90M*$46.72M*
2017-09-30-$5.75M*$8.97M*-$167.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
CG Oncology, Inc. (CGON)United States$6.095B-27.95
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29